Literature DB >> 12046625

Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy.

Paul Dowling1, Kevin Culligan, Kay Ohlendieck.   

Abstract

Unique unaffected skeletal muscle fibres. unlike necrotic torso and limb muscles, may pave the way for a more detailed understanding of the molecular pathogenesis of inherited neuromuscular disorders and help to develop new treatment strategies for muscular dystrophies. The sparing of extraocular muscle in Duchenne muscular dystrophy is mostly attributed to the special protective properties of extremely fast-twitching small-diameter fibres, but here we show that distal muscles also represent a particular phenotype that is more resistant to necrosis. Immunoblot analysis of membranes isolated from the well established dystrophic animal model mdx shows that, in contrast to dystrophic limb muscles, the toe musculature exhibits an up-regulation of the autosomal dystrophin homologue utrophin and a concomitant rescue of dystrophin-associated glycoproteins. Thus distal mdx muscle groups provide a cellular system that naturally avoids myofibre degeneration which might be useful in the search for naturally occurring compensatory mechanisms in inherited skeletal muscle diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12046625     DOI: 10.1007/s00114-001-0289-4

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  9 in total

1.  The regulatory utilization of genetic redundancy through responsive backup circuits.

Authors:  Ran Kafri; Melissa Levy; Yitzhak Pilpel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-21       Impact factor: 11.205

Review 2.  Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.

Authors:  Jane T Seto; Julian N Ramos; Lindsey Muir; Jeffrey S Chamberlain; Guy L Odom
Journal:  Curr Gene Ther       Date:  2012-06       Impact factor: 4.391

Review 3.  Proteomic profiling of x-linked muscular dystrophy.

Authors:  Caroline Lewis; Steven Carberry; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2009-12       Impact factor: 2.698

Review 4.  The muscular dystrophies: from genes to therapies.

Authors:  Richard M Lovering; Neil C Porter; Robert J Bloch
Journal:  Phys Ther       Date:  2005-12

Review 5.  What do mouse models of muscular dystrophy tell us about the DAPC and its components?

Authors:  Charlotte Whitmore; Jennifer Morgan
Journal:  Int J Exp Pathol       Date:  2014-09-30       Impact factor: 1.925

6.  Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage.

Authors:  Kevin J Morine; Meg M Sleeper; Elisabeth R Barton; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2010-12       Impact factor: 5.695

7.  Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice.

Authors:  Guy L Odom; Paul Gregorevic; James M Allen; Eric Finn; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-07-29       Impact factor: 11.454

8.  Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.

Authors:  Paul Dowling; Philip Doran; Kay Ohlendieck
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

9.  Mass Spectrometric Profiling of Extraocular Muscle and Proteomic Adaptations in the mdx-4cv Model of Duchenne Muscular Dystrophy.

Authors:  Stephen Gargan; Paul Dowling; Margit Zweyer; Jens Reimann; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  Life (Basel)       Date:  2021-06-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.